Wearable Infusion Pumps Market Report 2026

Wearable Infusion Pumps Market Overview

• Wearable Infusion Pumps market size has reached to $1.51 billion in 2025 • Expected to grow to $2.36 billion in 2030 at a compound annual growth rate (CAGR) of 9.3% • Growth Driver: Growing Chronic Disease Rates To Drive Wearable Infusion Pumps Market Expansion • Market Trend: Advancements In Tubeless, Wearable Insulin Pumps Propel The Wearable Infusion Pump Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Wearable Infusion Pumps Market?

A wearable infusion pump is a portable medical device designed to deliver precise doses of medication or fluids over an extended period of time. It is typically worn on the body and provides continuous or intermittent infusion, offering convenience and flexibility for patients. The main types of wearable infusion pumps are electronic ambulatory infusion pumps, patient-controlled analgesia (PCA) pumps, large-volume pumps, syringe pumps, and others. Electronic ambulatory infusion pumps are portable infusion devices that use electronic controls to deliver precise doses of medication continuously over time. The various usages include disposable and reusable for varying applications such as diabetes, antibiotic infusions, chemotherapy, pain management, Parkinson's disease, and others.

What Is The Wearable Infusion Pumps Market Growth Forecast?

The wearable infusion pumps market size is expected to see strong growth in the next few years. It will grow to $2.36 billion in 2030 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to adoption of AI-based dose optimization, integration with smartphone and cloud platforms, growth in multi-drug delivery applications, demand for compact and portable wearable pumps, increasing telehealth services for chronic care management. Major trends in the forecast period include smart wearable insulin pumps, remote monitoring and telehealth integration, ai-driven dose optimization, multi-drug infusion systems, compact and portable device designs.

Global Wearable Infusion Pumps Market Segmentation

1) By Type: Electronic Ambulatory Infusion Pumps, Patient-Controlled Analgesia (PCA) Pumps, Large Volume Pumps, Syringe Pumps, Other Types 2) By Usage: Disposable, Reusable 3) By Application: Diabetes, Antibiotic Infusion, Chemotherapy, Pain Management, Parkinson's Disease, Other Applications Subsegments: 1) By Electronic Ambulatory Infusion Pumps: Portable Infusion Pumps, Implantable Infusion Pumps 2) By Patient-Controlled Analgesia (PCA) Pumps: Continuous PCA Pumps, Demand PCA Pumps 3) By Large Volume Pumps: Volumetric Pumps, Gravity Pumps 4) By Syringe Pumps: Infusion Syringe Pumps, Ambulatory Syringe Pumps 5) By Other Types: Insulin Pumps, Chemotherapy Pumps

What Is The Driver Of The Wearable Infusion Pumps Market?

The increasing prevalence of chronic diseases is expected to propel the growth of the wearable infusion pump market going forward. Chronic diseases are long-term health conditions that usually progress slowly and persist for a year or more, often requiring ongoing medical attention. Some of the major chronic diseases include cancer, heart disease, diabetes, cancer, and arthritis. The prevalence of chronic diseases is rising due to factors such as a combination of genetic, environmental, and lifestyle factors, including poor diet, lack of exercise, and exposure to toxins. Wearable infusion pumps aid chronic disease patients by providing continuous, precise delivery of medications, enhancing adherence, and optimizing treatment. For instance, in June 2024, according to the National Health Service, a UK-based publicly funded healthcare system In England, 3,615,330 individuals were registered with a GP for non-diabetic hyperglycemia (pre-diabetes) in 2023, representing an 18% increase from 3,065,825 in 2022. This growth highlights a significant rise in pre-diabetes cases year-over-year. Therefore, the increasing prevalence of chronic diseases will drive the wearable infusion pump industry.

Key Players In The Global Wearable Infusion Pumps Market

Major companies operating in the wearable infusion pumps market are Fresenius SE & Co. KGaA, Medtronic Plc, Medline Industries Inc., Becton Dickinson and Company, Baxter International Inc., B. Braun Melsungen AG, Nipro Corporation, ICU Medical Inc., Insulet Corporation, Sorenson Medical, Avanos Medical Inc., Vygon SA, pfm medical GmbH, Eitan Medical, Micrel Medical Devices SA, Zyno Medical LLC, Q-Core Medical Ltd., Epic Medical Solutions, MOOG Inc., Smiths Medical International Ltd

Global Wearable Infusion Pumps Market Trends and Insights

Major companies operating in the wearable infusion pump market are developing advanced products such as tubeless, wearable, and disposable insulin pumps to enhance user convenience, improve treatment adherence, and provide more efficient and discreet insulin delivery options for diabetes management. A tubeless, wearable, and disposable insulin pump is a small, skin-adhered device that offers continuous insulin delivery without external tubes and is replaced after a set period. For instance, in February 2023, GulfDrug LLC, a UAE-based healthcare company, launched EOPatch. This innovative product is a tubeless, wearable, and disposable insulin pump that can be controlled directly from Android and iOS smartphones using the Narsha app. The key features include up to 84 hours of continuous insulin delivery, simplifying the replacement cycle to twice a week, and the ability to communicate with certain blood glucose meters via Bluetooth. The Narsha app, the first smartphone application approved for this purpose, combines insulin delivery control and diabetes data management, eliminating the need for a separate controller.

What Are Latest Mergers And Acquisitions In The Wearable Infusion Pumps Market?

In June 2023, Lohmann Therapie-Systeme AG (LTS), a Germany-based drug delivery system company, acquired Sorrel from Eitan Medical for $100 million. With this acquisition, LTS aims to enhance its range of drug delivery systems by incorporating Eitan Medical's subsidiary Sorrel, it is a drug delivery platform that includes wearable pumps. Eitan Medical is an Israel-based company that specializes in innovative infusion and drug delivery solutions, including wearable infusion pumps such as patient-controlled epidural analgesia, focusing on enhancing patient care with advanced medical technology.

Regional Outlook

North America was the largest region in the wearable infusion pump market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Wearable Infusion Pumps Market?

The wearable infusion pump market consists of sales of infusion sets, reservoirs, and adhesive patches. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.